Robert J. Carman

4.8k total citations · 1 hit paper
135 papers, 3.7k citations indexed

About

Robert J. Carman is a scholar working on Infectious Diseases, Electrical and Electronic Engineering and Molecular Biology. According to data from OpenAlex, Robert J. Carman has authored 135 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Infectious Diseases, 42 papers in Electrical and Electronic Engineering and 18 papers in Molecular Biology. Recurrent topics in Robert J. Carman's work include Clostridium difficile and Clostridium perfringens research (53 papers), Laser Design and Applications (25 papers) and Plasma Diagnostics and Applications (23 papers). Robert J. Carman is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (53 papers), Laser Design and Applications (25 papers) and Plasma Diagnostics and Applications (23 papers). Robert J. Carman collaborates with scholars based in United States, Australia and United Kingdom. Robert J. Carman's co-authors include Richard P. Mildren, Mahfuzur R. Sarker, Bruce A. McClane, S. P. Borriello, Christopher W. Genheimer, Paul R. Barber, A.C. Tropper, C.J. Mackechnie, Helen M. Pask and Judith M. Dawes and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Journal of Applied Physics.

In The Last Decade

Robert J. Carman

131 papers receiving 3.6k citations

Hit Papers

Ytterbium-doped silica fiber lasers: versatile sources fo... 1995 2026 2005 2015 1995 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert J. Carman United States 34 1.6k 1.2k 781 596 476 135 3.7k
W. A. Gillespie United Kingdom 35 512 0.3× 778 0.6× 231 0.3× 720 1.2× 772 1.6× 178 3.5k
Kazuo Imai Japan 24 999 0.6× 1.1k 1.0× 408 0.5× 254 0.4× 276 0.6× 174 2.9k
Dragana Vuković Serbia 18 1.2k 0.8× 325 0.3× 2.5k 3.1× 425 0.7× 196 0.4× 61 4.7k
Yoshikazu Ishii Japan 35 770 0.5× 223 0.2× 1.3k 1.7× 806 1.4× 139 0.3× 261 4.4k
Takeshi Yokota Japan 37 1.3k 0.8× 354 0.3× 1.4k 1.8× 388 0.7× 196 0.4× 190 4.2k
Paul Southern United States 33 704 0.4× 221 0.2× 557 0.7× 649 1.1× 185 0.4× 129 4.2k
Kenichi Imai Japan 28 533 0.3× 451 0.4× 717 0.9× 329 0.6× 268 0.6× 155 2.8k
T. Kumagai Japan 39 223 0.1× 606 0.5× 1.6k 2.0× 434 0.7× 151 0.3× 258 5.4k
Yong Shin South Korea 30 365 0.2× 353 0.3× 971 1.2× 191 0.3× 294 0.6× 143 2.6k
Hajime Goto Japan 31 896 0.6× 268 0.2× 344 0.4× 1.3k 2.2× 152 0.3× 200 3.7k

Countries citing papers authored by Robert J. Carman

Since Specialization
Citations

This map shows the geographic impact of Robert J. Carman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert J. Carman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert J. Carman more than expected).

Fields of papers citing papers by Robert J. Carman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert J. Carman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert J. Carman. The network helps show where Robert J. Carman may publish in the future.

Co-authorship network of co-authors of Robert J. Carman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert J. Carman. A scholar is included among the top collaborators of Robert J. Carman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert J. Carman. Robert J. Carman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Young, Mary K., Jhansi L. Leslie, Gregory R. Madden, et al.. (2022). Binary Toxin Expression by Clostridioides difficile Is Associated With Worse Disease. Open Forum Infectious Diseases. 9(3). ofac001–ofac001. 19 indexed citations
2.
Boyle, G. J., et al.. (2019). Thermalisation time of electron swarms in xenon for uniform electric fields. Plasma Sources Science and Technology. 28(3). 35009–35009. 6 indexed citations
3.
Carman, Robert J., et al.. (2018). Multidrug resistant Clostridium difficile ribotype 027 in southwestern Virginia, 2007 to 2013. Anaerobe. 52. 16–21. 8 indexed citations
5.
Boone, James H., Laurie Archbald‐Pannone, Robert J. Carman, et al.. (2014). Ribotype 027 Clostridium difficile infections with measurable stool toxin have increased lactoferrin and are associated with a higher mortality. European Journal of Clinical Microbiology & Infectious Diseases. 33(6). 1045–1051. 23 indexed citations
6.
Archbald‐Pannone, Laurie, James H. Boone, Robert J. Carman, David M. Lyerly, & Richard L. Guerrant. (2014). Clostridium difficile ribotype 027 is most prevalent among inpatients admitted from long-term care facilities. Journal of Hospital Infection. 88(4). 218–221. 16 indexed citations
8.
Wigelsworth, Darran J., Gordon Ruthel, Peter Herrlich, et al.. (2012). CD44 Promotes Intoxication by the Clostridial Iota-Family Toxins. PLoS ONE. 7(12). e51356–e51356. 39 indexed citations
10.
Stare, Barbara Gerič, Robert J. Carman, Maja Rupnik, et al.. (2006). Binary Toxin–Producing, Large Clostridial Toxin–NegativeClostridium difficileStrains Are Enterotoxic but Do Not Cause Disease in Hamsters. The Journal of Infectious Diseases. 193(8). 1143–1150. 157 indexed citations
11.
Carman, Robert J., et al.. (2004). Ciprofloxacin at low levels disrupts colonization resistance of human fecal microflora growing in chemostats. Regulatory Toxicology and Pharmacology. 40(3). 319–326. 31 indexed citations
12.
Carman, Robert J., et al.. (2001). Effects of Low Levels of Ciprofloxacin on a Chemostat Model of the Human Colonic Microflora. Regulatory Toxicology and Pharmacology. 33(3). 276–284. 21 indexed citations
13.
Abrahão, Carlos Roberto, Robert J. Carman, Helmut Hahn, & Oliver Liesenfeld. (2001). Similar Frequency of Detection of Clostridium perfringens Enterotoxin and Clostridium difficile Toxins in Patients with Antibiotic-Associated Diarrhea. European Journal of Clinical Microbiology & Infectious Diseases. 20(9). 676–677. 33 indexed citations
15.
Carman, Robert J., et al.. (1999). DIAGNOSIS AND TREATMENT OF CLOSTRIDIAL COLITIS IN A MARE. Veterinary medicine. 94(4). 363–366. 2 indexed citations
16.
Snel, J., et al.. (1995). Comparison of 16S rRNA Sequences of Segmented Filamentous Bacteria Isolated from Mice, Rats, and Chickens and Proposal of "Candidatus Arthromitus". International Journal of Systematic Bacteriology. 45(4). 780–782. 133 indexed citations
17.
Carman, Robert J., et al.. (1992). Porphyromonas gingivalis: Presence of a Species-specific Antigen which is Discriminatory in Chronic Inflammatory Adult Periodontal Disease. Microbial Ecology in Health and Disease. 5(1). 15–20. 6 indexed citations
18.
Wilton, James, Newell W. Johnson, Michael A. Curtis, et al.. (1991). Specific antibody responses to subgingival plaque bacteria as aids to the diagnosis and prognosis of destructive periodontitis*. Journal Of Clinical Periodontology. 18(1). 1–15. 50 indexed citations
19.
Carman, Robert J., et al.. (1988). Conversion of IQ, a dietary pyrolysis carcinogen to a direct-acting mutagen by normal intestinal bacteria of humans. Mutation Research/Genetic Toxicology. 206(3). 335–342. 52 indexed citations
20.
Hager, Jean Carol, Robert J. Carman, Ronald G. Stoller, et al.. (1978). A prototype for a hybrid artificial liver.. PubMed. 24. 250–3. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026